us food and drug administration

Hope for Duchenne sufferers around the world

April 27th, 2017

16-year-old Billy Ellsworth is still walking thanks to Western Australian researchers who developed the first drug to address the underlying genetic defect of Duchenne, and the first of its type to be approved by the US Food and Drug Administration.

+ Find out more

World breakthrough for WA researchers

September 20th, 2016

The FDA has approved a drug developed in Perth by Professors Sue Fletcher and Steve Wilton

The international Duchenne muscular dystrophy community have applauded the announcement by the US Food and Drug Administration (FDA) to approve a drug developed in Perth by Professors Steve Wilton and Sue Fletcher

+ Find out more

Omics Symposium features influential line-up

September 20th, 2012

The upcoming 2012 Omics Australasia Symposium (OA2012) will feature an elite line-up of world experts in the growing field of ‘Omics’ research.

+ Find out more